← Eichor
Condition: Immune Related Dermatitis Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Immune Related Dermatitis

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Origin and Function of Eosinophilic Polynuclear During DRESS Syndrome
Phase N/A · 11 location(s) · University Hospital, Lille · NCT04330118Evaluation of the Efficacy and Safety of Methylprednisolone Combined With the JAK Inhibitors in the Treatment of Toxic E
EARLY_Phase 1 · 1 location(s) · Peng Zhang · NCT06119490Prospective Longitudinal Observational Research in Atopic Dermatitis
Phase N/A · 1 location(s) · University of Zurich · NCT04240522LYell SYndrome MEsenchymal Stromal Cells Treatment
Phase 1/Phase 2 · 1 location(s) · Assistance Publique - Hôpitaux de Paris · NCT04711200An Observational Retrospective Cohort Study Being Conducted in Women With Atopic Dermatitis Exposed to Ruxolitinib Cream
Phase N/A · 1 location(s) · Incyte Corporation · NCT06627335Environmental Exposure to Heavy Metals, Nanoparticles, and Emergent Contaminants and Risk of Allergic Diseases
NA · 2 location(s) · Fondazione Policlinico Universitario Agostino Gemelli IRCCS · NCT06529913Study to Compare Maternal, Fetal, and Infant Outcomes of Women With Mild to Moderate Atopic Dermatitis Exposed to Ruxoli
Phase N/A · 1 location(s) · Incyte Corporation · NCT06259669Active Pharmacovigilance Study of the Medicine Rinvoq™ (Upadacitinib)
Phase N/A · 3 location(s) · Universidade do Porto · NCT06498167Natural History and Genetics of Food Allergy and Related Conditions
Phase N/A · 1 location(s) · National Institute of Allergy and Infectious Diseases (NIAID · NCT02504853A Study to Assess the Impact of Lebrikizumab on Health-Related Well-Being and Control of Skin Manifestations in Particip
Phase N/A · 1 location(s) · Almirall, S.A. · NCT06815380Drug Reactions Sampling (COLLECTIONTOXIDERMIES)
Phase N/A · 1 location(s) · Assistance Publique - Hôpitaux de Paris · NCT03659227Healthy-donor Microbiome MTP-101-C in Steroid Relapse/Refractory Immune-related Cutaneous Adverse Events (irCAEs) and Im
Phase 2 · 1 location(s) · Diwakar Davar · NCT06499896Sand Play - the Effect of Biodiversity Exposure on Atopic Dermatitis
NA · 2 location(s) · Natural Resources Institute Finland · NCT06390696JAK Inhibitors for Solid Malignant Tumor Patients With Immune Checkpoint Inhibitors-related Dermatitis: A Open-lable, Si
Phase 2 · 1 location(s) · Shixiu Wu · NCT06715982
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.